Pathology labs generate vast amounts of data every day, which goes beyond just glass slides. This data encompasses gross pathology specimen photos, image annotation...
Aiosyn is proud to announce the first results of an independent clinical performance study conducted for its Aiosyn Mitosis Breast solution. This study was performed at Radboud university medical center (Nijmegen, the Netherlands) and involved a diverse group of certified pathologists from around the globe.
In Kenya, the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) has recently procured advanced diagnostic equipment from the Japan International Cooperation Agency (JICA) via the Ministry of Health’s National Cancer Control Program. As the only level 5 hospital in Western Kenya, JOOTRH's enhanced telepathology capabilities are critical for the ten surrounding counties. Their recent acquisitions include a series of cutting-edge Leica systems: an Automated tissue processor, Autostainer, Automated microtome, Slide labeler, Embedding Station, Cassette printer, and Slide scanner.
Imagine having just a few slices from a loaf of bread and trying to visualize the entire loaf. This analogy mirrors the challenges faced by scientists who aim to understand the three-dimensional structure of biological tissues using only two-dimensional slices. The difficulties are compounded when we consider the inherent warping of tissue samples during lab procedures.
Paige, a global leader in end-to-end digital pathology solutions and clinical AI, developed the first Large Foundation Model using over one billion images from half a million pathology slides across multiple cancer types. Paige is developing with Microsoft a new AI model that is orders-of-magnitude larger than any other image-based AI model existing today, configured with billions of parameters. This model assists in capturing the subtle complexities of cancer and serves as the cornerstone for the next generation of clinical applications and computational biomarkers that push the boundaries of oncology and pathology.
A Guide to Better Immunohistochemistry: To get a confident diagnosis, labs must do all they can to ensure that their IHC stains exhibit the highest standards of quality. On some days, this can be tough, and root...
Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded the prestigious KWF (Dutch Cancer Society) grant as part of an international consortium in collaboration with Radboudumc, Mayo Clinic, Netherlands Cancer Institute (NKI), APSS Hospital, UNIBS Hospital, IRCC Hospital, German Breast Group, and the Medical University Vienna. The project will develop and validate AI for breast cancer grading and validate new computational biomarkers. This may lead to a new digital biomarker strategy that will support therapeutic decision-making for important breast cancer subgroups.
The research team meticulously curated relevant posts from 2006-2022, finally collating over 200,000 image-text pairs. This collection, named OpenPath, is now a giant in public datasets of human-annotated pathology images.
This is a skin mass from a 9-year-old crossbreed canine. This is a densely cellular, 7.5mm diameter, well demarcated, unencapsulated, multinodular, pedunculated mass within the dermis of haired skin. It consists of vascular spaces of various...
by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a recent pilot validation study, researchers at the University of California Davis Health and the University of British Columbia compared a novel imaging method called fluorescence imitating brightfield imaging (FIBI) with the standard formalin-fixed, paraffin-embedded (FFPE) hematoxylin-eosin (H&E) stained tissue section histology for primary surgical pathology [...]
